Xcellerex Manufacturing Facility

With an initial meeting to set design intent just after Labor Day, the client was able to move into their new facility just five months later. The facility will house five manufacturing lines that will operate 24/7 and significantly increase Cytiva’s capacity to manufacture Xcellerex Bioreactors, which provide the flexible and scalable solutions drug developers need to manufacture biopharmaceuticals. In addition to new manufacturing space, the building features a new factory acceptance testing suite, dedicated Automation and Digital server room and expanded office, café and meeting space.